Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes

Journal of Experimental Medicine

Volumn 184, Issue 3, 1996, Pages 945-954

  Sinnis, Photini ^a   Willnow, Thomas E ^b   Briones, Marcelo R S ^a   Herz, Joachim ^b   Nussenzweig, Victor ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; HEPARAN SULFATE; LACTOFERRIN; LIPOPROTEIN; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; VERY LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ANIMAL; ANOPHELES; ARTICLE; BLOOD; LIVER; MALARIA; METABOLISM; MOUSE; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; PLASMODIUM; ANIMAL CELL; HUMAN; HUMAN CELL; LIVER CELL; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; SPOROZOITE;

ANIMALS; ANOPHELES; APOLIPOPROTEINS E; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; LACTOFERRIN; LIPOPROTEINS; LIPOPROTEINS, VLDL; LIVER; MALARIA; MICE; PLASMODIUM; PROTEOGLYCANS;

EID: 0029658307     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.184.3.945     Document Type: Article

References (61)

1. Cooper, A.D. 1992. Hepatic clearance of plasma chylomicron remnants. Semin. Liver Dis. 12:386-396.
2. Gotto, A.M., H.J. Pownall, and R.J. Havel. 1986. Introduction to the plasma lipoproteins. Methods Enzymol. 128:3-41.
3. Sherril, B.C., T.L. Innerarity, and R.W. Mahley. 1980. Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. Identity with the chylomicron remnant transport process. J. Biol. Chem, 255:1804-1807.
4. Shelburne, F., J. Hanks, W. Meyers, and S. Quarfordt. 1980. Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat. J. Clin. Invest. 65:652-658.
5. Windier, E., Y.S. Chao, and R.J. Havel. 1980. Determinants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat. J. Biol. Chem. 255:5475-5480.
6. Schaefer, E.J., R.E. Gregg, G. Ghiselli, T.M. Forte, J.M. Ordovas, L.A. Zech, and H.B. Brewer. 1986. Familial apolipoprotein E deficiency. J. Clin. Invest. 78:1206-1219.
7. Zhang, S.H., R.L. Reddick, J.A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science (Wash. DC). 258: 468-471.
8. Plump, A.S., J.D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, J.G. Verstuyft, E.M. Rubin, and J.L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:343-353.
9. Ji, Z., S. Fazio, Y. Lee, and R.W. Mahley. 1994. Secretioncapture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J. Biol. Chem. 269:2764-2772.
10. Ji, Z., W.J. Brecht, R.D. Miranda, M.M. Hussain, T.L. Innerarity, and R.W. Mahley. 1993. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268:10160-10167.
11. Herz, J., Q. Shi-Qiang, A. Oesterle, H.V. DeSilva, S. Shafi, and R.J. Havel. 1995. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 92:4611-4615.
12. Mahley, R.W., Z. Ji, W.J. Brecht, R.D. Miranda, and D. He. 1994. Role of heparan sulfate proteoglycans and the LDL receptor-related protein in remnant lipoprotein metabolism. In Biology of a2-Macroglobulin, Its Receptor, and Related Proteins. W. Borth, R.D. Feinman, S.L. Gonias, J.P. Quigley, and D.K. Strickland, editors. New York Academy of Sciences, New York. 39-52.
13. Willnow, T.E., J.L. Goldstein, K. Orth, M.S. Brown, andj. Herz. 1992. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J. Biol. Chem. 267:26172-26180.
14. Zou, S., C.E. Magura, and W.L. Hurley. 1992. Heparin-binding properties of lactoferrin and lysozyme. Comp. Biochem. Physiol. 103B:889-895.
15. Huettinger, M., H. Retzek, M. Eder, and H. Goldenberg. 1988. Characteristics of chylomicron remnant uptake into rat liver. Clin. Biochem. 21:87-92.
16. Huettinger, M., H. Retzek, M. Hermann, and H. Goldenberg. 1992. Lactoferrin specifically inhibits endocytosis of chylomicron remnants but not a-macroblobulin. J. Biol. Chem. 267:18551-18557.
17. Nussenzweig, V., and R.S. Nussenzweig. 1989. Rationale for the development of an engineered sporozoite malaria vaccine. Adv. Immunol. 45:283-334.
18. Cerami, C., U. Frevert, P. Sinnis, B. Takacs, and V. Nussenzweig. 1994. Rapid clearance of malaria circumsporozoite protein (CS) by hepatocytes. J. Exp. Med. 179:695-701.
19. Frevert, U., P. Sinnis, C. Cerami, W. Shreffler, B. Takacs, and V. Nussenzweig. 1993. Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes. J. Exp. Med. 177:1287-1298.
20. Pancake, S.J., G.H. Holt, S. Mellouk, and S.L. Hoffman. 1992. Malaria sporozoites and circumsporozoite proteins bind specifically to sulfated glycoconjugates. J. Cell Biol. 6:1351-1357.
21. Cerami, C., U. Frevert, P. Sinnis, B. Takacs, P. Clavijo, M.J. Santos, and V. Nussenzweig. 1992. The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites. Cell. 70:1021-1035.
22. Sinnis, P., P. Clavijo, D. Fenyo, B.T. Chait, C. Cerami, and V. Nussenzweig. 1994. Structural and functional properties of region II-plus of the malaria circumsporozoite protein. J. Exp. Med. 180:297-306.
23. Dame, J.B., J.L. Williams, T.F. McCutchan, J.L. Weber, R.A. Wirtz, W.T. Hockmeyer, W.L. Maloy, J.D. Haynes, I. Schneider, D.D. Roberts et al. 1984. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science (Wash. DC). 225:593-599.
24. Robson, K.J.H., J.R.S. Hall, M.W. Jennings, T.J.R. Harris, K. Marsh, C.I. Newbold, V.E. Tate, and D.J. Weatherall. 1988. A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature (Lond.). 335: 79-82.
25. Rogers, W.O., M.D. Rogers, R.C. Hedstrom, and S.L. Hoffman. 1992. Characterization of the gene encoding sporozoite surface protein 2, a protective Plasmodium yoelii sporozoite antigen. Mol. Biochem. Parasitol. 53:45-52.
26. Muller, H.M., I. Reckman, M.R. Hollingdale, H. Bujard, K.J.H. Robson, and A. Crisanti. 1993. Thrombospondin related anonymous protein (TRAP) of Plasmodium falciparum binds specifically to sulfated glycoconjugates and to HepG2 hepatoma cells suggesting a role for this molecule in sporozoite invasion of hepatocytes. EMBO (Eur. Mol. Biol. Organ.) J. 12:2881-2889.
27. Robson, K.J.H., U. Frevert, I. Reckmann, G. Cowan, J. Beier, I.G. Scragg, K. Takehara, D.H.L. Bishop, G. Pradel, R. Sinden et al. 1995. Thrombospondin-related adhesive protein (TRAP) of Plasmodium falciparum: expression during sporozoite ontogeny and binding to human hepatocytes. EMBO (Eur. Mol. Biol. Organ.) J. 14:3883-3894.
28. Ziere, G.J., M.K. Bijsterbosch, and T.J.C. van Berkel. 1993. Removal of 14 N-terminal amino acids of lactoferrin enhances its affinity for parenchymal liver cells and potentiates the inhibition of β-very low density lipoprotein binding. J. Biol. Chem. 268:27069-27075.
29. Ziere, G.J., M.C.M. van Dijk, M.K. Bijsterbosch, and T.J.C. van Berkel. 1992. Lactoferrin uptake by the rat liver. J. Biol. Chem. 267:11229-11235.
30. Cardin, A.D., N. Hirose, D.T. Blankenship, R.L. Jackson, and J.A.K. Harmony. 1986. Binding of a high reactive heparin human apolipoprotein E: identification of two heparinbinding domains. BBRC (Biochem. Biophys. Res. Commun.). 134:783-789.
31. Weisgraber, K.H., S.C. Rail, R.W. Mahley, R.W. Milne, Y.L. Marcel, and J.T. Sparrow. 1986. Human apolipoprotein E: determination of the heparin binding sites of apolipoprotein E3. J. Biol. Chem. 261:2068-2076.
32. Takacs, B.J., and M.F. Girard. 1991. Preparation of clinical grade proteins produced by recombinant DNA technologies. J. Immunol. Methods. 143:231-240.
33. Vogel, T., K.H. Weisgraber, M.I. Zeevi, H. Ben-Artzi, A.Z. Levanon, S.C. Rail, T.L. Innerarity, D.Y. Hui, J.M. Taylor, D. Kanner et al. 1985. Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E. Proc. Natl. Acad. Sci. USA. 82:8696-8700.
34. Nardin, E.H., V. Nussenzweig, R.S. Nussenzweig, W.E. Collins, K.T. Harinasuta, P. Tapchaisri, and Y. Chomcham. 1982. Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J. Exp. Med. 156: 20-30.
35. Tsuji, M., D. Mattei, R.S. Nussenzweig, D. Eichinger, and F. Zavala. 1994. Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites. Parasitol. Res. 80:16-21.
36. Kowal, R.C., J. Herz, K.H. Weisgraber, R.W. Mahley, M.S. Brown, and J.L. Goldstein. 1990. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J. Biol. Chem. 265: 10771-10779.
37. Ishibashi, S., M.S. Brown, J.L. Goldstein, R.D. Gerard, R.E. Hammer, and J. Herz. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92: 883-893.
38. Ishibashi, S., J. Herz, N. Maeda, J.L. Goldstein, and M.S. Brown. 1994. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc. Natl. Acad. Sci. USA. 91:4431-4435.
39. Hollingdale, M.R., M. McCullough, and R.L. Beaudoin. 1981. In vitro cultivation of the exoerythrocytic stage of Plasmodium berghei from sporozoites. Science (Wash. DC). 213: 1021-1022.
40. Sinden, R.E., A. Suhrbier, C.S. Davies, S.L. Fleck, K. Hodivala, andJ.C. Nicholas. 1990. The development and routine application of high-density exoerythrocytic-stage cultures of Plasmodium berghei. Bull. W. H. O. 68(suppl.)115-125.
41. Briones, M.R.S., M. Tsuji, and V. Nussenzweig. 1996. The large difference in infectivity for mice of Plasmodium berghei and Plasmodium yoelii sporozoites cannot be correlated with their ability to enter into hepatocytes. Mol. Biochem. Parasitol. 77:7-17.
42. Reiner, S.L., S. Zheng, D.B. Corry, and R.M. Locksley. 1993. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods. 165:37-46.
43. Kowal, R.C., J. Herz, J.L. Goldstein, V. Esser, and M.S. Brown. 1989. Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc. Natl. Acad. Sci. USA. 86:5810-5814.
44. Lusis, A.J., B.A. Taylor, D. Quon, S. Zollman, and R.C. Le-Boeuf. 1987. Genetic factors controlling structure and expression of apolipoproteins B and E in mice. J. Biol. Chem. 262:7594-7604.
45. Ji, Z., D.A. Sanan, and R.W. Mahley. 1995. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans. J. Lipid Res. 36:583-592.
46. Kjellen, L., and U. Lindahl. 1991. Proteoglycans: structures and interactions. Annu. Rev. Biochem. 60:443-475.
47. Lyon, M., J.A. Deakin, and J.T. Gallagher. 1994. Liver heparan sulfate structure. J. Biol. Chem. 269:11208-11215.
48. Gallagher, J.T., and A. Walker. 1985. Molecular distinctions between heparan sulphate and heparin. Biochem.J. 230:665-674.
49. Yoshida, N., R.S. Nussenzweig, P. Potocnjak, V. Nussenzweig, and M. Aikawa. 1980. Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science (Wash. DC). 207:71-73.
50. Kjellen, L., A. Oldberg, and M. Hook. 1980. Cell-surface heparan sulfate. J. Biol. Chem. 255:10407-10413.
51. Yanagishita, M., and V. Hascall. 1992. Cell surface heparan sulfate proteoglycans. J. Biol. Chem. 267:9451-9454.
52. Charoenvit, Y., M.F. Leef, L.F. Yuan, M. Sedegah, and R.L. Beaudoin. 1987. Characterization of Plasmodium yoelii mono clonal antibodies directed against stage-specific sporozoite antigens. Infect. Immun. 55:604-608.
53. Cowan, G., S, Krishna, A. Crisanti, and K. Robson. 1992. Expression of thrombospondin-related anonymous protein in Plasmodium falciparum sporozoites. Lancet. 339:1412-1413.
54. Vanderberg, J., S. Chew, and M.J. Stewart. 1990. Plasmodium sporozoite interactions with macrophages in vitro: a videomicroscopic analysis. J. Protozool. 37:528-536.
55. Dobrowolski, J.M., and L.D. Sibley. 1996. Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell. 84:933-939.
56. + cytotoxic T-cell clone recognizing sporozoite surface protein 2. Infect. Immun. 62:2979-2983.
57. Wisse, E., R.B. De Zanger, P. Van der Smissen, and R.S. McCuskey. 1985. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology. 5:683-692.
58. Brabin, B. 1990. An analysis of malaria parasite rates in infants: 40 years after MacDonald. Trap. Dis. Bull. 87: R1-R21.
59. Greenwood, B.M. 1991. An analysis of malaria parasite rates in infants: 40 years after MacDonald a response. Trop. Dis. Bull. 88: R1-R3.
60. Knapp, R.D., and T.W. Hutchens. 1994. Maternal lactoferrin in the urine of preterm infants. Evidence for retention of structure and function. Adv. Exp. Med. and Biol. 357:177-181.
61. Motil, K.J. 1987. Breast Feeding: Public Health and Clinical Overview. In Pediatric Nutrition. R.J. Grand, J.L. Sutphen, and W.H. Dietz, editors. Butterworth, Stoneham, MA. 251-263.